M K Proteins Ltd (MKPL) — shareholding pattern, promoter holding, financials and share price
About M K Proteins Ltd (MKPL)
M K Proteins Ltd operates in the Edible Oil industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as MKPL and on the BSE under scrip code 543919. Its ISIN is INE964W01021.
Incorporated in 2012, M K Proteins Ltd is engaged in manufacturing, trading, and production of Edible Oils [1]
MK Proteins Limited is a company engaged in the manufacturing and trading of edible oils, based in Haryana, India.
The company specializes in refining crude oils to produce various products like Refined Rice Bran Oil, Canola Oil, and Sunflower Oil.
Listed peers in Edible Oil: Integrated Proteins Ltd, Vijay Solvex Ltd, Ajanta Soya Ltd, Ambar Protein Industries Ltd, Prime Industries Ltd, Sarda Proteins Ltd.
Valuation & Returns
10 Jul 2026At ₹4.62 a share on 10 Jul 2026, M K Proteins Ltd (MKPL) was valued at a price-to-earnings ratio of 25.39x against an industry P/E of 33.81x and a price-to-book of 2.5x on a book value of ₹1.85 per share as of Mar 2025. Solomo computes return on equity of 9.83% and return on capital employed of 10.4% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 25.39x
- Industry P/E
- 33.81x
- P/B
- 2.5x
- EPS (TTM)
- ₹0.18
- Book value / share
- ₹1.85
- ROE
- 9.83%
- ROCE
- 10.4%
- ROA
- 5.23%
- Debt / equity
- 0.56x
- Dividend yield
- 0%
- EBITDA margin
- 3.05%
- 52-week range
- ₹3.8 – ₹8.84
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, M K Proteins Ltd (MKPL) reported revenue of ₹383 crore, net profit of ₹7 crore and earnings per share of ₹0.18. That compares with revenue of ₹268 crore and net profit of ₹8 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹145.94 crore and net profit ₹1.14 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 256 | 315 | 245 | 268 | 383 |
| Net profit (₹ cr) | 10 | 11 | 11 | 8 | 7 |
| EPS (₹) | 0.27 | 0.29 | 0.3 | 0.22 | 0.18 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 7.05% | 6.64% | 1.52% | 9.02% |
| Profit growth | 31.34% | 35.82% | -6.23% | -25.07% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.82% of M K Proteins Ltd (MKPL) (unchanged from the previous quarter). Market capitalisation was ₹173 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2017.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.82% | - | - | - | 25.18% |
| Mar 2026 | 74.82% | - | - | - | 25.18% |
| Dec 2025 | 74.82% | - | - | - | 25.18% |
| Sep 2025 | 74.82% | - | - | - | 25.18% |
| Jun 2025 | 74.82% | - | - | - | 25.18% |
| Mar 2025 | 74.82% | - | - | - | 25.18% |
| Dec 2024 | 74.82% | - | - | - | 25.18% |
| Sep 2024 | 74.82% | - | 0% | - | 25.18% |